Agilent Technologies' and PREMIER Biosoft's Platforms Work Together to Advance Lipidomics Research

Santa Clara and Palo Alto, California --  Agilent Technologies Inc. (NYSE: A) and PREMIER Biosoft today announced that they will each support the combined use of their respective technologies to help clinical researchers advance lipidomics research. By integrating complementary technologies, researchers can seamlessly generate and process data, then map complex lipidomic networks to learn more about lipid metabolism associated with disease.

The power of Agilent's industry-leading time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software combined with Premier Biosoft's SimLipid 3.3 identification and quantification software enables researchers to overcome many of the obstacles inherent in lipid identification and analysis. This will give them a distinct advantage in their efforts to map the lipid pathways associated with metabolic disease.

More from Electrical Equipment & Systems

All Topics